The Daily Biotech Pulse: Kura's Blood Cancer Drug Study Gets Partial Clinical Hold, Takeda FDA Nod,...

Published on 24 Nov 2021 on Benzinga

The Daily Biotech Pulse: Kura's Blood Cancer Drug Study Gets Partial Clinical Hold, Takeda FDA Nod,...

Here's a roundup of top developments in the biotech space over the last 24 hours.

Puma Biotechnology, Inc. (NASDAQ: PBYI) announced the U.S. Patent and Trademark Office issued a patent term extension certificate, extending the patent regarding the composition of matter claims for its breast cancer drug Nerlynx by five years.

Read the rest of the article

NASDAQ.KURA price evolution

NYSE.TAK price evolution

NASDAQ.CNTG price evolution

NASDAQ.BGNE price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Why Is Kura Oncology, Inc. (KURA) Among the Best Small-Cap Biotech Stocks With...

We recently compiled a list of the 10 Best Small-Cap Biotech Stocks with Massive Potential Accord...

Insider Monkey · via Yahoo Finance 4 Dec 2024

Kura Oncology, Inc. (KURA): Among the Most Promising Cancer Stocks According to...

We recently compiled a list of the 10 Most Promising Cancer Stocks According to Hedge Funds. In t...

Insider Monkey · via Yahoo Finance 23 Nov 2024

Kura Oncology, Inc. (KURA): This Small-Cap Healthcare Stock Is A Good Buy Right...

We recently compiled a list of the 10 Best Small-Cap Healthcare Stocks To Buy Now. In this articl...

Insider Monkey · via Yahoo Finance 21 Aug 2024

Estimating The Intrinsic Value Of Kura Oncology, Inc. (NASDAQ:KURA)

Key Insights Kura Oncology's estimated fair value is US$25.13 based on 2 Stage Free Cash Flow to...

Simply Wall St. · via Yahoo Finance 20 Jun 2024

2 Incredible Growth Stocks to Buy Hand Over Fist

Growth stocks have resoundingly outperformed value and dividend stocks since the 2008 financial c...

Motley Fool via Yahoo Finance 8 May 2024

Kura Oncology, Inc. (NASDAQ:KURA) Q1 2024 Earnings Call Transcript

Kura Oncology, Inc. (NASDAQ:KURA) Q1 2024 Earnings Call Transcript May 4, 2024 Kura Oncology, Inc...

Insider Monkey via Yahoo Finance 6 May 2024

Kura Oncology, Inc. (NASDAQ:KURA) Q4 2023 Earnings Call Transcript

Kura Oncology, Inc. (NASDAQ:KURA) Q4 2023 Earnings Call Transcript February 27, 2024 Kura Oncolog...

Insider Monkey via Yahoo Finance 28 Feb 2024

Chief Medical Officer Stephen Dale Sells Shares of Kura Oncology Inc

Stephen Dale, Chief Medical Officer of Kura Oncology Inc, has sold 11,983 shares of the company o...

GuruFocus.com via Yahoo Finance 4 Feb 2024

Is There An Opportunity With Kura Oncology, Inc.'s (NASDAQ:KURA) 42% Undervaluation?

Key Insights Using the 2 Stage Free Cash Flow to Equity, Kura Oncology fair value estimate is US$...

Simply Wall St. via Yahoo Finance 28 Jan 2024

Why Is Cancer Focused Kura Oncology Stock Is Trading Higher Today?

Kura Oncology Inc (NASDAQ:KURA) shares are trading higher after the announced $150 million privat...

Benzinga via Yahoo Finance 21 Jan 2024

News

The Daily Biotech Pulse: Kura's Blood Cancer Drug Study Gets Partial Clinical Hold, Takeda FDA Nod,...

NASDAQ.KURA price evolution

NYSE.TAK price evolution

NASDAQ.CNTG price evolution

NASDAQ.BGNE price evolution

Want to become a better investor?